| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.7M | -31.2% |
| Cost of Revenue | $19.8M | -24.8% |
| R&D Expense | $6.0M | -18.9% |
| SG&A Expense | $17.2M | -5.5% |
| Operating Income | -$29.5M | -43.1% |
| Net Income | -$29.5M | -46.4% |
| EPS (Basic) | -$0.84 | +12.1% |
| EPS (Diluted) | -$0.84 | +12.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $472K | -69.8% |
| Accounts Receivable | $1.6M | -58.4% |
| Current Assets | $2.4M | -82.4% |
| Total Assets | $15.2M | -55.6% |
| Current Liabilities | $7.5M | +63.4% |
| Total Liabilities | $7.5M | +63.3% |
| Stockholders' Equity | $7.7M | -74.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.7M | +6.7% |
| Investing Cash Flow | $7.2M | +872.1% |
| Financing Cash Flow | $7.4M | -53.4% |